These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 31181979)

  • 1. Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Lin TK; Hsu BC; Li YD; Chen CH; Lin JW; Chien CY; Weng CY
    J Am Heart Assoc; 2019 Jun; 8(12):e010739. PubMed ID: 31181979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Depressive Symptoms for Cardiovascular Events in Female Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Zhao H; Jiang J; Zhong G; Peng Y; Wen Y; Liang Y; Shan Z
    J Am Heart Assoc; 2024 May; 13(9):e032961. PubMed ID: 38686893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes.
    Park JJ; Mebazaa A; Hwang IC; Park JB; Park JH; Cho GY
    J Am Heart Assoc; 2020 Jun; 9(12):e015009. PubMed ID: 32519555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
    JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline.
    Smith GL; Masoudi FA; Vaccarino V; Radford MJ; Krumholz HM
    J Am Coll Cardiol; 2003 May; 41(9):1510-8. PubMed ID: 12742291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics, Comorbidities and Prognosis in Patients With Heart Failure With Mid-Range Ejection Fraction.
    Murtaza G; Paul TK; Rahman ZU; Kelvas D; Lavine SJ
    Am J Med Sci; 2020 Jun; 359(6):325-333. PubMed ID: 32354595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.
    Almahmoud MF; Soliman EZ; Bertoni AG; Kestenbaum B; Katz R; Lima JAC; Ouyang P; Miller PE; Michos ED; Herrington DM
    J Am Heart Assoc; 2018 Sep; 7(18):e008334. PubMed ID: 30371180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).
    Tsuchihashi-Makaya M; Hamaguchi S; Kinugawa S; Yokota T; Goto D; Yokoshiki H; Kato N; Takeshita A; Tsutsui H;
    Circ J; 2009 Oct; 73(10):1893-900. PubMed ID: 19644216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.